129 related articles for article (PubMed ID: 12818362)
1. Involvement of nuclear transcription factor-kappa B in low-dose doxorubicin-induced drug resistance of cervical carcinoma cells.
Yeh PY; Chuang SE; Yeh KH; Song YC; Cheng AL
Biochem Pharmacol; 2003 Jul; 66(1):25-33. PubMed ID: 12818362
[TBL] [Abstract][Full Text] [Related]
2. Increase of the resistance of human cervical carcinoma cells to cisplatin by inhibition of the MEK to ERK signaling pathway partly via enhancement of anticancer drug-induced NF kappa B activation.
Yeh PY; Chuang SE; Yeh KH; Song YC; Ea CK; Cheng AL
Biochem Pharmacol; 2002 Apr; 63(8):1423-30. PubMed ID: 11996883
[TBL] [Abstract][Full Text] [Related]
3. Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells.
Chuang SE; Yeh PY; Lu YS; Lai GM; Liao CM; Gao M; Cheng AL
Biochem Pharmacol; 2002 May; 63(9):1709-16. PubMed ID: 12007574
[TBL] [Abstract][Full Text] [Related]
4. Nuclear factor-kappaB mediates up-regulation of cathepsin B by doxorubicin in tumor cells.
Bien S; Ritter CA; Gratz M; Sperker B; Sonnemann J; Beck JF; Kroemer HK
Mol Pharmacol; 2004 May; 65(5):1092-102. PubMed ID: 15102937
[TBL] [Abstract][Full Text] [Related]
5. Nuclear Transcription Factor Kappa B Downregulation Reduces Chemoresistance in Bone Marrow-derived Cells Through P-glycoprotein Modulation.
Loaiza B; Hernández-Gutierrez S; Montesinos JJ; Valverde M; Rojas E
Arch Med Res; 2016 Feb; 47(2):78-88. PubMed ID: 27259382
[TBL] [Abstract][Full Text] [Related]
6. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells.
Ku JM; Kim SR; Hong SH; Choi HS; Seo HS; Shin YC; Ko SG
Mol Cell Biochem; 2015 Nov; 409(1-2):33-43. PubMed ID: 26169986
[TBL] [Abstract][Full Text] [Related]
7. Biological and chemical inhibitors of NF-kappaB sensitize SiHa cells to cisplatin-induced apoptosis.
Venkatraman M; Anto RJ; Nair A; Varghese M; Karunagaran D
Mol Carcinog; 2005 Sep; 44(1):51-9. PubMed ID: 16044419
[TBL] [Abstract][Full Text] [Related]
8. NF-kappa B-mediated chemoresistance in breast cancer cells.
Weldon CB; Burow ME; Rolfe KW; Clayton JL; Jaffe BM; Beckman BS
Surgery; 2001 Aug; 130(2):143-50. PubMed ID: 11490342
[TBL] [Abstract][Full Text] [Related]
9. Alopecurone B reverses doxorubicin-resistant human osteosarcoma cell line by inhibiting P-glycoprotein and NF-kappa B signaling.
Xia YZ; Ni K; Guo C; Zhang C; Geng YD; Wang ZD; Yang L; Kong LY
Phytomedicine; 2015 Mar; 22(3):344-51. PubMed ID: 25837271
[TBL] [Abstract][Full Text] [Related]
10. Curcumin reverses chemoresistance of human gastric cancer cells by downregulating the NF-κB transcription factor.
Yu LL; Wu JG; Dai N; Yu HG; Si JM
Oncol Rep; 2011 Nov; 26(5):1197-203. PubMed ID: 21811763
[TBL] [Abstract][Full Text] [Related]
11. Akt associates with nuclear factor kappaB and plays an important role in chemoresistance of gastric cancer cells.
Yu LL; Dai N; Yu HG; Sun LM; Si JM
Oncol Rep; 2010 Jul; 24(1):113-9. PubMed ID: 20514451
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression.
Notarbartolo M; Poma P; Perri D; Dusonchet L; Cervello M; D'Alessandro N
Cancer Lett; 2005 Jun; 224(1):53-65. PubMed ID: 15911101
[TBL] [Abstract][Full Text] [Related]
13. [Reversion of resistance to cisplatin induced by MG132 in cervical cancer line HCE1 multicellular spheroid].
Wu YL; Yang HJ; Wang KK; Tao GS; Liu YZ; Hu Y
Zhonghua Fu Chan Ke Za Zhi; 2010 Apr; 45(4):287-91. PubMed ID: 20646542
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin.
Arlt A; Vorndamm J; Breitenbroich M; Fölsch UR; Kalthoff H; Schmidt WE; Schäfer H
Oncogene; 2001 Feb; 20(7):859-68. PubMed ID: 11314019
[TBL] [Abstract][Full Text] [Related]
15. Adriamycin activates NF-kappaB in human lung carcinoma cells by IkappaBalpha degradation.
Andriollo M; Favier A; Guiraud P
Arch Biochem Biophys; 2003 May; 413(1):75-82. PubMed ID: 12706343
[TBL] [Abstract][Full Text] [Related]
16. IkappaBalpha gene therapy in tumor necrosis factor-alpha- and chemotherapy-mediated apoptosis of hepatocellular carcinomas.
Tietze MK; Wuestefeld T; Paul Y; Zender L; Trautwein C; Manns MP; Kubicka S
Cancer Gene Ther; 2000 Oct; 7(10):1315-23. PubMed ID: 11059688
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of constitutive activity of nuclear transcription factor kappaB sensitizes doxorubicin-resistant cells to apoptosis.
Gangadharan C; Thoh M; Manna SK
J Cell Biochem; 2009 May; 107(2):203-13. PubMed ID: 19242952
[TBL] [Abstract][Full Text] [Related]
18. Evidence that activation of nuclear factor-kappaB is essential for the cytotoxic effects of doxorubicin and its analogues.
Ashikawa K; Shishodia S; Fokt I; Priebe W; Aggarwal BB
Biochem Pharmacol; 2004 Jan; 67(2):353-64. PubMed ID: 14698047
[TBL] [Abstract][Full Text] [Related]
19. Phosphoinositide 3-kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death.
Yu HG; Ai YW; Yu LL; Zhou XD; Liu J; Li JH; Xu XM; Liu S; Chen J; Liu F; Qi YL; Deng Q; Cao J; Liu SQ; Luo HS; Yu JP
Int J Cancer; 2008 Jan; 122(2):433-43. PubMed ID: 17935137
[TBL] [Abstract][Full Text] [Related]
20. Reversal of physiological stress-induced resistance to topoisomerase II inhibitors using an inducible phosphorylation site-deficient mutant of I kappa B alpha.
Brandes LM; Lin ZP; Patierno SR; Kennedy KA
Mol Pharmacol; 2001 Sep; 60(3):559-67. PubMed ID: 11502888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
